Form 4: Xencor Director Acquires Shares, Vesting Schedule Detailed
Insider Transaction Report
Xencor Director Barbara Klencke acquired 10,302 shares of common stock and was granted options for 20,604 shares, with specific vesting schedules outlined.
Summary
- Barbara Klencke, a Director at Xencor Inc. (XNCR), acquired 10,302 shares of common stock on June 16, 2026, at no cost.
- Additionally, Klencke was granted stock options for 20,604 shares of common stock on June 16, 2026, with an exercise price of $12.20.
- The acquired restricted stock units are set to fully vest on the first anniversary of the grant date.
- The shares subject to the stock options will vest in equal monthly installments over one year, starting one month after June 16, 2026, with full vesting by June 16, 2027.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it primarily details routine insider transactions related to compensation rather than significant strategic or financial performance indicators.
Positives
- Director acquisition of company stock can signal confidence in the company's future prospects.
- Granting of stock options provides an incentive for the director to contribute to the company's long-term growth and stock price appreciation.
Negatives
- The filing does not provide details on the rationale behind the acquisition or option grant, making it difficult to assess the specific positive implications.
Risks
- The value of the stock options is subject to market fluctuations and the company's future stock performance.
- If the company's stock price does not rise above the exercise price of $12.20, the stock options may not be exercised profitably.
Future Outlook
The future outlook for the stock options is dependent on the company's performance and stock price appreciation, with full vesting expected by June 16, 2027.
Industry Context
StockSavvy.ai notes that insider transactions, such as stock acquisitions and option grants, are common in the biotechnology and pharmaceutical sectors as a means of executive compensation and aligning management interests with shareholder value.
Stakeholder Impact
- Shareholders: The acquisition of stock by a director may be viewed positively, suggesting confidence in the company's future. The stock options provide a long-term incentive for the director to enhance shareholder value.
- Employees: The compensation structure for directors, including stock options, is part of the broader compensation framework within the company.
- Management: The filing details compensation elements for a key member of management (Director).
Next Steps
- Monitoring the vesting of restricted stock units and stock options.
- Observing Xencor's stock performance relative to the option exercise price.
Key Dates
| Date | Description |
|---|---|
| 06/16/2026 | Earliest transaction date, date of acquisition of common stock and grant of stock options. |
| 06/15/2036 | Expiration date of stock options. |
| 06/16/2027 | Date by which all granted stock options are fully vested. |
| 07/08/2026 | Date of filing signature. |
Keywords
Xencor, XNCR, Form 4, Insider Trading, Stock Options, Restricted Stock Units, Beneficial Ownership, Director Compensation, Securities Exchange Act
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.